Qtron Investments’s Takeda Pharmaceutical TAK Stock Holding History

Qtron Investments’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$188K	Hold	11,757	–	–	0.03%	446
2026 Q1	$218K	Hold	11,757	–	–	0.03%	413
2025 Q4	$183K	Buy	+11,757	New	+$168K	0.02%	424
2024 Q3	–	Sell	-43,020	Closed	-$557K	–	480
2024 Q2	$557K	Hold	43,020	–	–	0.08%	297
2024 Q1	$598K	Sell	43,020 -15,836	-27%	-$230K	0.08%	310
2023 Q4	$840K	Hold	58,856	–	–	0.14%	195
2023 Q3	$911K	Buy	58,856 +9,058	+18%	+$140K	0.17%	148
2023 Q2	$782K	Buy	49,798 +19,710	+66%	+$323K	0.15%	183
2023 Q1	$496K	Hold	30,088	–	–	0.1%	272
2022 Q4	$469K	Hold	30,088	–	–	0.1%	272
2022 Q3	$390K	Sell	30,088 -13,810	-31%	-$192K	0.1%	279
2022 Q2	$616K	Buy	43,898 +30,088	+218%	+$429K	0.14%	211
2022 Q1	$198K	Buy	+13,810	New	+$203K	0.04%	328

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Qtron Investments's TAK Position: Q2 2026 in Review

Qtron Investments held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 11,757 shares worth $188K. The position accounts for 0.03% of the portfolio, ranked #446.

Qtron Investments first reported a position in TAK in Q1 2022 and has held it in 13 quarters since. The position peaked at $911K in Q3 2023. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Qtron Investments held 11,757 shares of Takeda Pharmaceutical worth $188K as of Q2 2026.
Qtron Investments left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up 0.03% of Qtron Investments's portfolio in Q2 2026, its #446 holding.
Qtron Investments first reported a position in Takeda Pharmaceutical in Q1 2022 and has held it in 13 quarters since.
Qtron Investments's Takeda Pharmaceutical position peaked at $911K in Q3 2023.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.